Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial

Lateral epicondylalgia (LE), a common overuse syndrome of the extensor muscle and tendons on the lateral epicondyle, causes persistent severe musculoskeletal pain on the outer part of the elbow. Fu’s subcutaneous needling (FSN), a newly invented subtype of acupuncture and dry needling, is a new tren...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Evidence-based complementary and alternative medicine 2022-03, Vol.2022, p.5951327-10
Hauptverfasser: Huang, Ching-Hsuan, Lin, Chun-Yen, Sun, Mao-Feng, Fu, Zhonghua, Chou, Li-Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue
container_start_page 5951327
container_title Evidence-based complementary and alternative medicine
container_volume 2022
creator Huang, Ching-Hsuan
Lin, Chun-Yen
Sun, Mao-Feng
Fu, Zhonghua
Chou, Li-Wei
description Lateral epicondylalgia (LE), a common overuse syndrome of the extensor muscle and tendons on the lateral epicondyle, causes persistent severe musculoskeletal pain on the outer part of the elbow. Fu’s subcutaneous needling (FSN), a newly invented subtype of acupuncture and dry needling, is a new trend and potential treatment of LE by targeting the myofascial trigger points (MTrPs). However, no scientific evidence is available to support this method. This study aims to evaluate the distal FSN treatment on the LE by measuring pain-related scales, such as visual analog scale (VAS), pressure pain threshold (PPT), muscle tissue hardness (TH), pain-free grip (PFG), and the functional outcome by a patient-rated tennis elbow evaluation (PRTEE) questionnaire study. A total of 60 LE patients were randomly divided into FSN (n = 30) and transcutaneous electrical nerve stimulation (TENS, n = 30) as the control group. Every subject was treated with three regimens and followed up for 15 days. Results showed that FSN has an immediate effect on VAS, PPT, TH, and PFG. Moreover, sustained effects on pain relief were followed up to 15 days. Pain remission was consistent with long-term PRTEE results. Overall, FSN is a safe and efficient therapy option for LE, significantly improving pain relief and activity difficulty with immediate, short-term, and long-term effectiveness. This trial is registered with ClinicalTrials.gov NCT03605563.
doi_str_mv 10.1155/2022/5951327
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8938053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2643814294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-144c7d458e0cf4aa061a09a69bd1486e39ed10f28069a0f024fcd220181d6dfc3</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi1ERUvhxhlZ4oIEobbXu2tzQKqiFJDCh6BI3KyJP7auHDvYu6CgHvo3-Hv8km5IiIADpxlpnnk177wIPaDkGaV1fcIIYye1rGnF2lvoiLacTjgT4va-bz8forulXBLCZNu2d9BhVVeM1oQeoauZc16DXuPk8Nnw8_pHwR-HhR56iDYNBb-11gQfO5wifrNODor2EPB59l1nM36ffOwLdinjOfQ2j6PZyusUzTpA6Dw8x6f4A0STlv67NXiaYp_Tr30I99CBg1Ds_V09Rp_OZufTV5P5u5evp6fzia5a0U8o57o1vBaWaMcBSEOBSGjkwlAuGltJayhxTJBGAnGEcacNY4QKahrjdHWMXmx1V8NiaY224w0Q1Cr7JeS1SuDV35PoL1SXviohK0HqahR4vBPI6ctgS6-WvmgbwvZJijXjxyVvGjmij_5BL9OQ42hvQ1WCcib5SD3dUjqnUrJ1-2MoUZtY1SZWtYt1xB_-aWAP_85xBJ5sgQsfDXzz_5e7AToVrEc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2643814294</pqid></control><display><type>article</type><title>Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial</title><source>PubMed Central Open Access</source><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Huang, Ching-Hsuan ; Lin, Chun-Yen ; Sun, Mao-Feng ; Fu, Zhonghua ; Chou, Li-Wei</creator><contributor>Zhang, Jianliang ; Jianliang Zhang</contributor><creatorcontrib>Huang, Ching-Hsuan ; Lin, Chun-Yen ; Sun, Mao-Feng ; Fu, Zhonghua ; Chou, Li-Wei ; Zhang, Jianliang ; Jianliang Zhang</creatorcontrib><description>Lateral epicondylalgia (LE), a common overuse syndrome of the extensor muscle and tendons on the lateral epicondyle, causes persistent severe musculoskeletal pain on the outer part of the elbow. Fu’s subcutaneous needling (FSN), a newly invented subtype of acupuncture and dry needling, is a new trend and potential treatment of LE by targeting the myofascial trigger points (MTrPs). However, no scientific evidence is available to support this method. This study aims to evaluate the distal FSN treatment on the LE by measuring pain-related scales, such as visual analog scale (VAS), pressure pain threshold (PPT), muscle tissue hardness (TH), pain-free grip (PFG), and the functional outcome by a patient-rated tennis elbow evaluation (PRTEE) questionnaire study. A total of 60 LE patients were randomly divided into FSN (n = 30) and transcutaneous electrical nerve stimulation (TENS, n = 30) as the control group. Every subject was treated with three regimens and followed up for 15 days. Results showed that FSN has an immediate effect on VAS, PPT, TH, and PFG. Moreover, sustained effects on pain relief were followed up to 15 days. Pain remission was consistent with long-term PRTEE results. Overall, FSN is a safe and efficient therapy option for LE, significantly improving pain relief and activity difficulty with immediate, short-term, and long-term effectiveness. This trial is registered with ClinicalTrials.gov NCT03605563.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/5951327</identifier><identifier>PMID: 35321501</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Acupuncture ; Elbow ; Pain ; Patients ; Questionnaires ; Remission ; Tendons ; Transcutaneous electrical nerve stimulation-TENS ; Variance analysis ; Visual thresholds</subject><ispartof>Evidence-based complementary and alternative medicine, 2022-03, Vol.2022, p.5951327-10</ispartof><rights>Copyright © 2022 Ching-Hsuan Huang et al.</rights><rights>Copyright © 2022 Ching-Hsuan Huang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Ching-Hsuan Huang et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-144c7d458e0cf4aa061a09a69bd1486e39ed10f28069a0f024fcd220181d6dfc3</citedby><cites>FETCH-LOGICAL-c378t-144c7d458e0cf4aa061a09a69bd1486e39ed10f28069a0f024fcd220181d6dfc3</cites><orcidid>0000-0002-3540-6225</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938053/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938053/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35321501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Zhang, Jianliang</contributor><contributor>Jianliang Zhang</contributor><creatorcontrib>Huang, Ching-Hsuan</creatorcontrib><creatorcontrib>Lin, Chun-Yen</creatorcontrib><creatorcontrib>Sun, Mao-Feng</creatorcontrib><creatorcontrib>Fu, Zhonghua</creatorcontrib><creatorcontrib>Chou, Li-Wei</creatorcontrib><title>Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Lateral epicondylalgia (LE), a common overuse syndrome of the extensor muscle and tendons on the lateral epicondyle, causes persistent severe musculoskeletal pain on the outer part of the elbow. Fu’s subcutaneous needling (FSN), a newly invented subtype of acupuncture and dry needling, is a new trend and potential treatment of LE by targeting the myofascial trigger points (MTrPs). However, no scientific evidence is available to support this method. This study aims to evaluate the distal FSN treatment on the LE by measuring pain-related scales, such as visual analog scale (VAS), pressure pain threshold (PPT), muscle tissue hardness (TH), pain-free grip (PFG), and the functional outcome by a patient-rated tennis elbow evaluation (PRTEE) questionnaire study. A total of 60 LE patients were randomly divided into FSN (n = 30) and transcutaneous electrical nerve stimulation (TENS, n = 30) as the control group. Every subject was treated with three regimens and followed up for 15 days. Results showed that FSN has an immediate effect on VAS, PPT, TH, and PFG. Moreover, sustained effects on pain relief were followed up to 15 days. Pain remission was consistent with long-term PRTEE results. Overall, FSN is a safe and efficient therapy option for LE, significantly improving pain relief and activity difficulty with immediate, short-term, and long-term effectiveness. This trial is registered with ClinicalTrials.gov NCT03605563.</description><subject>Acupuncture</subject><subject>Elbow</subject><subject>Pain</subject><subject>Patients</subject><subject>Questionnaires</subject><subject>Remission</subject><subject>Tendons</subject><subject>Transcutaneous electrical nerve stimulation-TENS</subject><subject>Variance analysis</subject><subject>Visual thresholds</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU1vEzEQhi1ERUvhxhlZ4oIEobbXu2tzQKqiFJDCh6BI3KyJP7auHDvYu6CgHvo3-Hv8km5IiIADpxlpnnk177wIPaDkGaV1fcIIYye1rGnF2lvoiLacTjgT4va-bz8forulXBLCZNu2d9BhVVeM1oQeoauZc16DXuPk8Nnw8_pHwR-HhR56iDYNBb-11gQfO5wifrNODor2EPB59l1nM36ffOwLdinjOfQ2j6PZyusUzTpA6Dw8x6f4A0STlv67NXiaYp_Tr30I99CBg1Ds_V09Rp_OZufTV5P5u5evp6fzia5a0U8o57o1vBaWaMcBSEOBSGjkwlAuGltJayhxTJBGAnGEcacNY4QKahrjdHWMXmx1V8NiaY224w0Q1Cr7JeS1SuDV35PoL1SXviohK0HqahR4vBPI6ctgS6-WvmgbwvZJijXjxyVvGjmij_5BL9OQ42hvQ1WCcib5SD3dUjqnUrJ1-2MoUZtY1SZWtYt1xB_-aWAP_85xBJ5sgQsfDXzz_5e7AToVrEc</recordid><startdate>20220314</startdate><enddate>20220314</enddate><creator>Huang, Ching-Hsuan</creator><creator>Lin, Chun-Yen</creator><creator>Sun, Mao-Feng</creator><creator>Fu, Zhonghua</creator><creator>Chou, Li-Wei</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3540-6225</orcidid></search><sort><creationdate>20220314</creationdate><title>Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial</title><author>Huang, Ching-Hsuan ; Lin, Chun-Yen ; Sun, Mao-Feng ; Fu, Zhonghua ; Chou, Li-Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-144c7d458e0cf4aa061a09a69bd1486e39ed10f28069a0f024fcd220181d6dfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acupuncture</topic><topic>Elbow</topic><topic>Pain</topic><topic>Patients</topic><topic>Questionnaires</topic><topic>Remission</topic><topic>Tendons</topic><topic>Transcutaneous electrical nerve stimulation-TENS</topic><topic>Variance analysis</topic><topic>Visual thresholds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Ching-Hsuan</creatorcontrib><creatorcontrib>Lin, Chun-Yen</creatorcontrib><creatorcontrib>Sun, Mao-Feng</creatorcontrib><creatorcontrib>Fu, Zhonghua</creatorcontrib><creatorcontrib>Chou, Li-Wei</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Ching-Hsuan</au><au>Lin, Chun-Yen</au><au>Sun, Mao-Feng</au><au>Fu, Zhonghua</au><au>Chou, Li-Wei</au><au>Zhang, Jianliang</au><au>Jianliang Zhang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2022-03-14</date><risdate>2022</risdate><volume>2022</volume><spage>5951327</spage><epage>10</epage><pages>5951327-10</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Lateral epicondylalgia (LE), a common overuse syndrome of the extensor muscle and tendons on the lateral epicondyle, causes persistent severe musculoskeletal pain on the outer part of the elbow. Fu’s subcutaneous needling (FSN), a newly invented subtype of acupuncture and dry needling, is a new trend and potential treatment of LE by targeting the myofascial trigger points (MTrPs). However, no scientific evidence is available to support this method. This study aims to evaluate the distal FSN treatment on the LE by measuring pain-related scales, such as visual analog scale (VAS), pressure pain threshold (PPT), muscle tissue hardness (TH), pain-free grip (PFG), and the functional outcome by a patient-rated tennis elbow evaluation (PRTEE) questionnaire study. A total of 60 LE patients were randomly divided into FSN (n = 30) and transcutaneous electrical nerve stimulation (TENS, n = 30) as the control group. Every subject was treated with three regimens and followed up for 15 days. Results showed that FSN has an immediate effect on VAS, PPT, TH, and PFG. Moreover, sustained effects on pain relief were followed up to 15 days. Pain remission was consistent with long-term PRTEE results. Overall, FSN is a safe and efficient therapy option for LE, significantly improving pain relief and activity difficulty with immediate, short-term, and long-term effectiveness. This trial is registered with ClinicalTrials.gov NCT03605563.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35321501</pmid><doi>10.1155/2022/5951327</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3540-6225</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2022-03, Vol.2022, p.5951327-10
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8938053
source PubMed Central Open Access; Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Acupuncture
Elbow
Pain
Patients
Questionnaires
Remission
Tendons
Transcutaneous electrical nerve stimulation-TENS
Variance analysis
Visual thresholds
title Efficacy of Fu’s Subcutaneous Needling on Myofascial Trigger Points for Lateral Epicondylalgia: A Randomized Control Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A35%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Fu%E2%80%99s%20Subcutaneous%20Needling%20on%20Myofascial%20Trigger%20Points%20for%20Lateral%20Epicondylalgia:%20A%20Randomized%20Control%20Trial&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Huang,%20Ching-Hsuan&rft.date=2022-03-14&rft.volume=2022&rft.spage=5951327&rft.epage=10&rft.pages=5951327-10&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/5951327&rft_dat=%3Cproquest_pubme%3E2643814294%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2643814294&rft_id=info:pmid/35321501&rfr_iscdi=true